Mark Bridgewater has 25 years of experience in the industry, having worked for established pharmaceutical and medical device CDMOs. He was appointed Vectura’s Chief Commercial Officer in 2020, and in this role he leads commercial strategy, business development and marketing activities for the company, which is currently focused on driving Vectura’s transformation strategy from a product development company to a specialty CDMO focused on inhaled drug development. Prior to joining Vectura in 2020, Mr. Bridgwater held various senior level commercial roles at Flex and Catalent.